Working to Improve Patient Outcomes
Cancer affects the health of millions of Americans. Studying molecular mechanisms that endow cells with malignant properties is an essential component of advancing pre-clinical studies and a key part of efforts to improve patient outcomes. The purpose of this NIH Centers for Biomedical Research Excellence (COBRE) grant is to establish the Center for Molecular Interactions in Cancer (CMIC) at the University of Arkansas for Medical Sciences (UAMS). The mission of the CMIC is to study molecular features and functional properties of biomolecules that drive cancer. The unifying theme of research among Center members is the coupling of structural biology and high-resolution imaging with precise, quantitative analysis of biochemical and cellular processes to understand how molecular interactions govern the initiation, progression and treatment of cancer. Our long-term goal is to leverage faculty mentoring, strategic recruitment, and cutting-edge core resources to develop a critical mass of investigators that will support a self-sustaining center in which research advances our knowledge of cancer through precise and comprehensive analyses of molecular events that impact malignant pathogenesis.
How to Acknowledge the CMIC
“Research reported in this [publication, release] was supported (in whole or in part) by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM152281. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”
For abstracts, a short note “Supported by a grant from the NIH/NIGMS – 1P20GM152281” will suffice.